Esophageal Diseases clinical trials

The registry lists 92 studies for Esophageal Diseases across more than 10 countries. 21 are recruiting or about to start. 33 of them are mainly about Esophageal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03. Counting its 18 narrower conditions too, such as Esophageal Neoplasms: 5,505 studies, 1,422 open.

Get an email when these change. Save the Esophageal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 39
Status unknown: 23
Recruiting: 18
Terminated: 5
Not yet recruiting: 3
Active, not recruiting: 2

Phase

Phase 2: 16
Phase 3: 10
Phase 4: 10
Phase 1: 6

Where

United States: 37
China: 13
Spain: 8
United Kingdom: 8
Korea, Republic of: 7
Germany: 6

Who runs them

Asian Institute of Gastroenterology, India (5) · Ellodi Pharmaceuticals, LP (4) · Korea University (4) · Hangzhou Cancer Hospital (3) · CDx Diagnostics (3) · Seoul National University Hospital (2) · Region Örebro County (2) · Changhai Hospital (2)

What is being tested here

Drugs under test in Esophageal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Camrelizumab	1	0	2
Dupilumab	1	1	1
Botulinum toxin type A	1	1	1
Benmelstobart	1	0	1
APT-1011	0	3	4
Cendakimab	0	2	2
Paclitaxel	0	0	2
Cisplatin	0	0	2
Fluorouracil	0	0	2
Omeprazole	0	0	1

Drug classes tested here Immune checkpoint inhibitors 2 open

Coming up

2phase 3 studies under way

7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Nov 2026Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients · Jiangxi Provincial Cancer Hospital
Dec 2026Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy · Bács-Kiskun County Teaching Hospital
May 2027The French EsoGastricTumours Data Base · University Hospital, Lille
Jun 2027Comparison of Conventional and Short Submucosal Tunnel Techniques in Type II Achalasia · Asian Institute of Gastroenterology, India
Jul 2027A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients · Stanford University
Nov 2027Implementing Enhanced Recovery After Surgery (ERAS) Protocol in Patients Undergoing Minimal Invasive Esophagectomy · Assiut University
Nov 2027Clinical Utility of WATS3D: A 5-Year Prospective Study · CDx Diagnostics

Who these studies take

Of the 18 Esophageal Diseases studies recruiting now, 9 (50%) set no upper age limit and 7 (39%) stop at 75 or younger. 3 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (17%) take healthy volunteers.

Recruiting studies that take each age, of 18
Age	Women	Men
10	2 (11%)	2 (11%)
18	15 (83%)	15 (83%)
30	15 (83%)	15 (83%)
40	15 (83%)	15 (83%)
50	15 (83%)	15 (83%)
65	15 (83%)	15 (83%)
75	15 (83%)	15 (83%)
85	11 (61%)	11 (61%)

Across all 92 studies, recruiting or not: 40% stop at 75 or younger and 13% at 65; 15% take children; 0% are for women only and 2% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 92. Browse all 92 → or search them.